Glow50.
About Glow50
Glow50 is studied in dermatological and anti-aging research, e.g. in relation to skin and pigmentation models. Like Glow70, Glow50 combines three distinct mechanisms: vascular signal amplification (TB-500), cell migration (BPC-157), and collagen-related gene expression via the copper component (GHK-Cu).
Research Application
Analogous to Glow70, Glow50 is regarded as a multi-component approach combining vascular, migration, and collagen mechanisms. The lower BPC-157 dose per vial makes the product a variant for research designs requiring a different component ratio.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
The evidence base for skin and pigmentation peptides is largely based on preclinical and early clinical investigations.
- Hsieh MJ, et al. J Mol Med. 2017;95(3):323–333. PMID 27847966
- Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PMID 29986520
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about Glow50?
We reply personally – via email or Telegram.